Ofev 150 mg, 60 tablets (Nintedanib 150 mg) by Boehringer Ingelheim.
Indications: Idiopathic pulmonary fibrosis, other chronic fibrosing ILDs with progressive phenotype and systemic sclerosis-associated ILD.
Administration: Oral, twice daily approximately 12 hours apart with food (150 mg standard; 100 mg dose-reduced).
Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Boehringer Ingelheim |
| Active ingredient | Nintedanib 150 mg (as esilate) per soft capsule — tyrosine kinase inhibitor. |
| Strength & pack | 60 soft capsules. |
| Form | Soft capsules |
| Storage | Store below 25–30 °C in the original package. Keep out of the sight and reach of children. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |